Kineta wants to change biotech investing from 'a black box' to shorter, transparent model

Kineta, a Seattle-based company founded in 2008, is a different type of biotech. Its co-founders, CEO Charles Magness and Chief Scientific Officer Shawn Iadonato, aren't just focusing on developing their drugs for chronic pain, infectious diseases and autoimmune diseases. They want to transform the risky world of biotech investing to help make innovative products, especially those being made in the Seattle area, more successful in the long-term. I chatted with Magness and Iadonato about why there's…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news